| Particulars |
|
|
|
| Company Name
| ERIS Lifesciences Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
13.61 |
B.V. (₹) |
189.30 |
| Sales(₹ Cr.) |
1,528.28 |
NP (₹ Cr.) |
296.92 |
| NP Var% |
-24.00 |
Div% |
0.00 |
| CPS(₹) |
29.30 |
EPS (₹) |
21.80 |
| Traded Value(₹ Lakhs) |
22.52 |
52 Week High |
1,593.00 |
| 52 Week Low |
810.00 |
Price BSE |
1,298.00 |
| Price NSE |
1,297.00 |
Market Capital (₹ Cr.) |
17,675.03 |
| P/C Ratio |
44.30 |
P/E Ratio |
59.50 |
| Price Vs.BV |
6.86 |
|
| Latest Quarter |
| Year End |
202409 |
Sales (₹ Cr.) |
428.75 |
| NP(₹ Cr.) |
28.10 |
NP Var % |
-76.00 |
| Trailing Twelve Months |
| Year End |
202409 |
Sales |
1,526.13 |
| OPM |
27.51 |
NP |
116.31 |
| NP Var% |
-72.03 |
EPS |
8.54 |
| PE |
152.04 |
|
|